Should You Buy Moderna Before May 12?

This ambitious biotech aims to launch 15 products over the coming five years.Moderna (MRNA -2.45%) stock soared earlier in the pandemic as the company developed its coronavirus vaccine and the product went on to generate billions of dollars in sales. But as demand for the vaccine declined, Moderna stock followed. Investors are worried about future growth since the vaccine is the biotech's only commercialized product.But things may be about to turn around for Moderna. The biotech company aims to bring as man ...